Literature DB >> 27142112

Evaluation of the intercept oral specimen collection device with HIV assays versus paired serum/plasma specimens.

G Beelaert1, L Van Heddegem2, M Van Frankenhuijsen1, G Vandewalle2, V Compernolle2, E Florence1, K Fransen3.   

Abstract

Oral fluid has many advantages over blood-based techniques: it is less invasive, eliminates the occupational risk associated with needle stick accidents and collection can be self-administrated. Each individual test is packaged with a corresponding collection device. This study tested the suitability of the Intercept Oral Specimen Collection Device for different HIV diagnostic tests: three different rapid HIV tests and two adapted ELISAs, which were evaluated and compared with a gold standard on blood. In addition a total IgG quantification was performed to demonstrate the quality of the specimen. HIV antibodies were detected with a sensitivity of 100%, 99.3%, 98.6%, 100% and 95.7% for, DPP, OraQuick, Aware, Genscreen and Vironostika respectively using the Intercept Collection Device. Respective specificities were 100%, 100%, 99.3%, 97.3% and 100%.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HIV rapid test; Intercept; Oral fluid

Mesh:

Substances:

Year:  2016        PMID: 27142112     DOI: 10.1016/j.jviromet.2016.04.014

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  2 in total

1.  Validation study of an automated chemiluminiscence assay to detect HIV antibodies in oral fluid specimens.

Authors:  Victoria González; Nalia López; Joan Grifols; Laia Egea; Belén Rivaya; Jun Hao Wang Wang; Jordi Casabona; Pere Joan Cardona
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-07       Impact factor: 5.103

2.  Prevalence and associated risk factors of HIV infections in a representative transgender and non-binary population in Flanders and Brussels (Belgium): Protocol for a community-based, cross-sectional study using time-location sampling.

Authors:  Niels De Brier; Judith Van Schuylenbergh; Hans Van Remoortel; Dorien Van den Bossche; Steffen Fieuws; Geert Molenberghs; Emmy De Buck; Guy T'Sjoen; Veerle Compernolle; Tom Platteau; Joz Motmans
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.